Journal article
Mass spectrometry-based proteomic quest for diabetes biomarkers.
- Shao S Division of Endocrinology, Tongji Hospital, Huazhong University of Science & Technology, Wuhan 430030, PR China; Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Wolfgang-Pauli-Str. 16, 8093, Switzerland. Electronic address: shaoshiying@hotmail.com.
- Guo T Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Wolfgang-Pauli-Str. 16, 8093, Switzerland.
- Aebersold R Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Wolfgang-Pauli-Str. 16, 8093, Switzerland; Faculty of Science, University of Zurich, 8057 Zurich, Switzerland. Electronic address: aebersold@imsb.biol.ethz.ch.
- 2015-01-04
Published in:
- Biochimica et biophysica acta. - 2015
Biomarker
Diabetes
Mass spectrometry
Proteomics
SWATH MS
Selected reaction monitoring
Animals
Biomarkers
Diabetes Mellitus
Humans
Mass Spectrometry
Proteomics
English
Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia, which affects hundreds of millions of individuals worldwide. Early diagnosis and complication prevention of DM are helpful for disease treatment. However, currently available DM diagnostic markers fail to achieve the goals. Identification of new diabetic biomarkers assisted by mass spectrometry (MS)-based proteomics may offer solution for the clinical challenges. Here, we review the current status of biomarker discovery in DM, and describe the pressure cycling technology (PCT)-Sequential Window Acquisition of all Theoretical fragment-ion (SWATH) workflow for sample-processing, biomarker discovery and validation, which may accelerate the current quest for DM biomarkers. This article is part of a Special Issue entitled: Medical Proteomics.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1016/j.bbapap.2014.12.012
- PMID 25556002
- Persistent URL
- https://sonar.ch/global/documents/253783
Statistics
Document views: 16
File downloads: